4//SEC Filing
Foresite Capital Fund II, L.P. 4
Accession 0001209191-19-047387
CIK 0001337553other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 8:52 PM ET
Size
20.0 KB
Accession
0001209191-19-047387
Insider Transaction Report
Form 4
Foresite Capital Fund II, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2019-08-23$23.42/sh+38,300$896,986→ 2,250,477 total(indirect: See Footnote) - Purchase
Common Stock
2019-08-21$23.25/sh+1,153$26,807→ 2,205,477 total(indirect: See Footnote) - Purchase
Common Stock
2019-08-22$23.68/sh+6,700$158,656→ 2,212,177 total(indirect: See Footnote)
Foresite Capital Management IV, LLC
10% Owner
Transactions
- Purchase
Common Stock
2019-08-22$23.68/sh+6,700$158,656→ 2,212,177 total(indirect: See Footnote) - Purchase
Common Stock
2019-08-21$23.25/sh+1,153$26,807→ 2,205,477 total(indirect: See Footnote) - Purchase
Common Stock
2019-08-23$23.42/sh+38,300$896,986→ 2,250,477 total(indirect: See Footnote)
Foresite Capital Fund IV, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2019-08-22$23.68/sh+6,700$158,656→ 2,212,177 total(indirect: See Footnote) - Purchase
Common Stock
2019-08-21$23.25/sh+1,153$26,807→ 2,205,477 total(indirect: See Footnote) - Purchase
Common Stock
2019-08-23$23.42/sh+38,300$896,986→ 2,250,477 total(indirect: See Footnote)
Tananbaum James B.
10% Owner
Transactions
- Purchase
Common Stock
2019-08-23$23.42/sh+38,300$896,986→ 2,250,477 total(indirect: See Footnote) - Purchase
Common Stock
2019-08-21$23.25/sh+1,153$26,807→ 2,205,477 total(indirect: See Footnote) - Purchase
Common Stock
2019-08-22$23.68/sh+6,700$158,656→ 2,212,177 total(indirect: See Footnote)
Foresite Capital Management II, LLC
10% Owner
Transactions
- Purchase
Common Stock
2019-08-21$23.25/sh+1,153$26,807→ 2,205,477 total(indirect: See Footnote) - Purchase
Common Stock
2019-08-23$23.42/sh+38,300$896,986→ 2,250,477 total(indirect: See Footnote) - Purchase
Common Stock
2019-08-22$23.68/sh+6,700$158,656→ 2,212,177 total(indirect: See Footnote)
Foresite Capital Management III, LLC
10% Owner
Transactions
- Purchase
Common Stock
2019-08-21$23.25/sh+1,153$26,807→ 2,205,477 total(indirect: See Footnote) - Purchase
Common Stock
2019-08-22$23.68/sh+6,700$158,656→ 2,212,177 total(indirect: See Footnote) - Purchase
Common Stock
2019-08-23$23.42/sh+38,300$896,986→ 2,250,477 total(indirect: See Footnote)
Foresite Capital Fund III, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2019-08-21$23.25/sh+1,153$26,807→ 2,205,477 total(indirect: See Footnote) - Purchase
Common Stock
2019-08-22$23.68/sh+6,700$158,656→ 2,212,177 total(indirect: See Footnote) - Purchase
Common Stock
2019-08-23$23.42/sh+38,300$896,986→ 2,250,477 total(indirect: See Footnote)
Footnotes (3)
- [F1]The shares are owned directly by Foresite Capital Fund III, L.P. ("FCF III"). Foresite Capital Management III, LLC ("FCM III"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a "group." Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
- [F2]This transaction was executed in multiple trades at prices ranging from $23.48 to $23.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $23.295 to $23.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
AERIE PHARMACEUTICALS INC
CIK 0001337553
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001594914
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 8:52 PM ET
- Size
- 20.0 KB